Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 3, 2008, Pages 980-990

  Muthaiyan, Arunachalam ^a   Silverman, Jared A ^b   Jayaswal, Radheshyam K ^a   Wilkinson, Brian J ^a  

^a ILLINOIS STATE UNIVERSITY   (United States)

^b CUBIST PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; DAPTOMYCIN; OXACILLIN; VANCOMYCIN;

ARTICLE; BACTERIAL CELL WALL; DRUG MECHANISM; GENE EXPRESSION PROFILING; MEMBRANE DEPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE; STIMULON; TRANSCRIPTION INITIATION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CELL MEMBRANE; CELL POLARITY; CELL WALL; DAPTOMYCIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HEAT-SHOCK RESPONSE; HUMANS; MICROBIAL SENSITIVITY TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STAPHYLOCOCCUS AUREUS;

EID: 40549087912     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01121-07     Document Type: Article

References (68)

1. Alborn, Jr., W. E., N. E. Allen, and D. A. Preston. 1991. Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob. Agents Chemother. 35:2282-2287.
2. Alder, J. D. 2005. Daptomycin, a new drug class for the treatment of gram-positive infections. Drugs Today (Barcelona) 41:81-90.
3. Allen, N. E., J. N. Hobbs, Jr., and W. E. Alborn, Jr. 1987. Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY 146032. Antimicrob. Agents Chemother. 31:1093-1099.
4. Balaban, N., T. Goldkorn, Y. Gov, M. Hirshberg, N. Koyfman, H. R. Mathews, R. T. Nhan, B. Singh, and O. Uziel. 2001. Regulation of Staphylococcus aureus pathogenesis via target of RNA III-activating protein (TRAP). J. Biol. Chem. 276:2658-2667.
5. Bandow, J. E., H. Brotz, L. I. O. Leichert, H. Labischinski, and M. Hecker. 2003. Proteomic approach to understanding antibiotic action. Antimicrob. Agents Chemother. 47:948-955.
6. Boaretti, M., P. Canepari, M. del Mar Lleò, and G. Satta. 1993. The activity of daptomycin on Enterococcus faecium protoplasts: indirect evidence supporting a novel mode of action on lipoteichoic acid synthesis. J. Antimicrob. Chemother. 31:227-235.
7. Boyle-Vavra, S., S. Yin, M. Challapalli, and R. S. Daum. 2003. Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin. Antimicrob. Agents Chemother. 47:1028-1036.
8. Boyle-Vavra, S., S. Yin, and R. S. Daum. 2006. The VraS/VraR two-component regulatory system required for oxacillin resistance in community-acquired methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 262:163-171.
9. Brandenberger, M., M. Tschierske, P. Giachino, A. Wada, and B. Berger-Bächi. 2000. Inactivation of a novel three-cistronic operon tcaR-tcaA-tcaB increases teicoplanin resistance in Staphylococcus aureus. Biochim. Biophys. Acta 1523:135-139.
10. Breukink, E., I. Wiedemann, C. van Kraaig, O. P. Kuipers, H.-G. Sahl, and B. de Kruijff. 1999. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286:2361-2364.
11. Brötz, H., M. Josten, I. Wiedemann, U. Schneider, F. Götz, G. Bierbaum, and H.-G. Sahl. 1998. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30:317-327.
12. Canepari, P., M. Boaretti, M. del Mar Lleò, and G. Satta. 1990. Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032). Antimicrob. Agents Chemother. 34:1220-1226.
13. Chamberlain, N. R., B. G. Mehrtens, Z. Xiong, F. A. Kapral, J. L. Boardman, and J. I. Rearick. 1991. Correlation of carotenoid production, decreased membrane fluidity, and resistance to oleic acid killing in Staphylococcus aureus 182. Infect. Immun. 59:4332-4337.
14. Clinical Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically; approved standard, 7th ed. M7.A7. Clinical and Laboratory Standards Institute, Wayne, PA.
15. Cui, L., X. Ma, K. Sato, K. Okuma, F. C. Tenover, E. M. Mamizuka, C. G. Gemmell, M. N. Kim, M. C. Ploy, N. El-Solh, V. Ferraz, and K. Hiramatsu. 2003. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microbiol. 41:5-14.
16. Cui, L., E. Tominaga, H.-M. Neoh, and K. Hiramatsu. 2006. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50:1079-1082.
17. Driessen, A. J. M., H. W. van der Hooven, W. Kuiper, M. van de Camp, H.-G. Sahl, R. N. H. Konings, and W. N. Konings. 1995. Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles. Biochemistry 34:1606-1614.
18. Eliopoulos, G. M. S., S. Willey, E. Reiszner, P. G. Spitzer, G. Caputo, and R. C. Moellering, Jr. 1986. In vitro and in vivo activity of LY146032, a new cyclic lipopeptide antibiotic. Antimicrob. Agents Chemother. 30:532-535.
19. Fuchs, S., J. Pané-Farré, C. Kohler, M. Hecker, and S. Engelmann. 2007. Anaerobic gene expression in Staphylococcus aureus. J. Bacteriol. 189:4275-4289.
20. Gardete, S., S. W. Wu, S. Gill, and A. Tomasz. 2006. Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus. Antimicrob. Agents Chemother. 50:3424-3434.
21. Hachmann, A. G., J. A. Silverman, and J. D. Helmann. 2007. The transcriptional response to daptomycin: defining the mechanisms of resistance in Bacillus subtilis, abstr. C1-1467. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother.
22. Harold, F. M. 1970. Antimicrobial agents and membrane function. Adv. Microb. Physiol. 4:45-104.
23. Harris, B., N. Cotroneo, J. A. Silverman, and T. Beveridge. 2004. Visualization of daptomycin-induced membrane and cell wall alterations in freeze-substituted Staphylococcus aureus, abstr. C1-941. Abstr. 44th Intersci. Conf. Antimicrob. Agents Chemother.
24. Hasper, H. E., N. E. Kramer, J. L. Smith, J. D. Hillman, C. Zachariah, O. P. Kruipers, B. de Kruijff, and E. Breukink. 2006. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 313:1636-1637.
25. Higgins, D. L., R. Chang, D. V. Debabov, J. Leung, T. Wu, K. M. Krause, E. Sandvik, J. M. Hubbard, K. Kaniga, D. E. Schmidt, Jr., Q. Gao, R. T. Cass, D. E. Karr, B. M. Benton, and P. P. Humphrey. 2005. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 49:1127-1134.
26. Hughes, T. R., C. J. Roberts, H. Dai, A. R. Jones, M. R. Meyer, D. Slade, J. Burchard, S. Dow, T. R. Ward, M. J. Kidd, S. H. Friend, and M. J. Marton. 2000. Widespread aneuploidy revealed by DNA microarray expression profiling. Nat. Genet. 25:333-337.
27. Hutter, B., C. Schaab, S. Albrecht, M. Borgmann, N. A. Brunner, C. Freiberg, K. Ziegelbaur, C. O. Rock, I. Ivanov, and H. Loeferer. 2004. Prediction of mechanisms of action of antibacterial compounds by gene expression profiling. Antimicrob. Agents Chemother. 48:2838-2844.
28. Jordan, S., A. Junker, J. D. Helmann, and T. Mascher. 2006. Regulation of LiaRS-dependent gene expression in Bacillus subtilis: identification of inhibitor proteins, regulator binding sites, and target genes of a conserved cell envelope stress-sensing two-component system. J. Bacteriol. 188:5153-5166.
29. Jung, D., A. Rozek, M. Ikon, and R. E. W. Hancock. 2004. Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. Chem. Biol. 11:949-957.
30. Kuroda, M., H. Kuroda, L. Cui, and K. Hiramatsu. 2007. Subinhibitory concentrations of β-lactam induce haemolytic activity in Staphylococcus aureus through the SaeRS two-component system. FEMS Microbiol. Lett. 268:98-105.
31. Kuroda, M., H. Kuroda, T. Oshima, F. Takeuchi, H. Mori, and K. Hiramatsu. 2003. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49:807-821.
32. Laganas, V., J. Alder, and J. A. Silverman. 2003. In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis. Antimicrob. Agents Chemother. 47:2682-2684.
33. Lai, Y., A. E. Villaruz, M. Li, D. J. Cha, D. E. Sturdevant, and M. Otto. 2007. The human anionic antimicrobial peptide dermicidin induces proteolytic defence mechanisms in staphylococci. Mol. Microbiol. 63:497-506.
34. Lakey, J. H., and M. Ptak. 1988. Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes. Biochemistry 27:4639-4645.
35. Lamichhane-Khadka, R., J. T. Riordan, A. Muthaiyan, B. J. Wilkinson, and J. E. Gustafson. 2007. Transcriptome and comparative genomic sequencing analysis reveals household disinfectant reduced susceptibility mechanism expressed by Staphylococcus aureus, abstr. A-045. Abstr. 107th Annu. Meet. Am. Soc. Microbiol.
36. Ledala, N., B. J. Wilkinson, and R. K. Jayaswal. 2006. Effects of oxacillin and tetracycline on autolysis, autolysin processing and atl transcription in Staphylococcus aureus. Intl. J. Antimicrob. Agents 27:518-524.
37. Maiques, E., C. Ubeda, S. Campoy, N. Salvador, I. Lasa, R. P. Novick, J. Barbe, and J. R. Penades. 2006. Beta-lactam antibiotics induce the SOS response and horizontal transfer of virulence factors in Staphylococcus aureus. J. Bacteriol. 188:2726-2729.
38. Marquardt, J. L., D. A. Siegele, R. Kolter, and C. T. Walsh. 1992. Cloning and sequence of Escherichia coli murZ and purification of its product, a UDP-N-acetylglucosamine enolpyruvyl transferase. J. Bacteriol. 174:5748-5752.
39. Martinez, B., A. L. Zomer, A. Rodriguez, J. Kok, and A. P. Kuipers. 2007. Cell envelope stress induced by the bacteriocin Lcn972 is sensed by the lactococcal two-component system CesSR. Mol. Microbiol. 64:473-486.
40. Mascio, C. T. M., J. Alder, and J. A. Silverman. 2005. Bactericidal action of daptomycin (DAP) against non-dividing Staphylococcus aureus, abstr. E-1743. Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother.
41. McAleese, F., S. W. Wu, K. Sieradzki, P. Dunman, E. Murphy, S. Projan, and A. Tomasz. 2006. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate-S. aureus-type resistance to vancomycin. J. Bacteriol. 188:1120-1133.
42. Miller, C., L. E. Thomsen, C. Gaggero, R. Mosseri, H. Ingmer, and S. N. Cohen. 2004. SOS response induction by β-lactams and bacterial defense against antibiotic lethality. Science 305:1629-1631.
43. Murakami, H., H. Matsumara, M. Kanamori, H. Hayashi, and T. Ohta. 1999. Cell wall-affecting antibiotics induce expression of a novel gene, drp35, in Staphylococcus aureus. Biochem. Biophys. Res. Commun. 264:348-351.
44. Muthaiyan, A., J. A. Silverman, R. K. Jayaswal, and B. J. Wilkinson. 2005. Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon, abstr. C1-1407. Abstr. 45th Intersci. Conf. Antimicrob. Agents. Chemother.
45. Mwangi, M. M., S. W. Wu, Y. Zhou, K. Sieradzki, H. deLencastre, P. Richardson, D. Bruce, E. Rubin, E. Myers, E. D. Siggia, and A. Tomasz. 2007. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. USA 104:9451-9456.
46. Patton, T. G., S.-J. Yang, and K. W. Bayles. 2006. The role of proton motive force in expression of the Staphylococcus aureus cid and lrg operons. Mol. Microbiol. 59:1395-1404.
47. Pechous, R., N. Ledala, B. J. Wilkinson, and R. K. Jayaswal. 2004. Regulation of the expression of cell wall stress stimulon member gene msrA1 in methicillin-susceptible or-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 48:3057-3063.
48. Pelz, A., K.-P. Wieland, K. Putzback, P. Hentschel, K. Albert, and F. Gotz. 2005. Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J. Biol. Chem. 280:32493-32498.
49. Pfletz, R. F., and B. J. Wilkinson. 2004. The escalating challenge of vancomycin resistance in Staphylococcus aureus. Curr. Drug Targets Infect. Dis. 4:273-294.
50. Pietiäinen, M., M. Gardemeister, M. Mecklin, S. Leskelä, M. Sarvas, and V. P. Kontinen. 2005. Cationic antimicrobial peptides elicit a complex stress response in Bacillus subtilis that involves ECF-type sigma factors and two-component signal transduction systems. Microbiology 151:1577-1592.
51. Pinho, M. G., H. de Lencastre, and A. Tomasz. 2001. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug resistant staphylococci. Proc. Natl. Acad. Sci. USA 98:10886-10991.
52. Pucci, M. J., J. A. Thanassi, H. T. Ho, P. J. Falk, and T. J. Dougherty. 1995. Staphylococcus haemolyticus contains two D-glutamic acid biosynthetic activities, a glutamate racemase and a D-amino acid transaminase. J. Bacteriol. 177:336-342.
53. Rice, K. C., and K. W. Bayles. 2003. Death's toolbox: examining the molecular components of bacterial programmed cell death. Mol. Microbiol. 50:729-738.
54. Sader, H. S., T. R. Fritsche, and R. N. Jones. 2006. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Antimicrob. Agents Chemother. 50:2330-2336.
55. Sahl, H.-G., and G. Bierbaum. 1998. Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. Annu. Rev. Microbiol. 52:41-79.
56. Sakoulos, G., J. Alder, C. Thavin-Eliopoulos, R. C. Moellering, Jr., and G. M. Eliopoulos. 2006. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob. Agents Chemother. 50:1581-1585.
57. Silverman, J. A., N. G. Perlmutter, and H. M. Shapiro. 2003. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 47:2538-2544.
58. Singh, V. K., R. K. Jayaswal, and B. J. Wilkinson. 2001. Cell wall-active antibiotic induced proteins of Staphylococcus aureus identified using a proteomic approach. FEMS Microbiol. Lett. 199:79-84.
59. Straus, S. K., and R. E. W. Hancock. 2006. Mode of action of the new antibiotic for gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim. Biophys. Acta 1758:1215-1223.
60. Stubbings, W. J., R. Bell, V. Ryder, M. Bedi, J. Keen, and I. Chopra. 2006. Proteomic investigation of the mode of action of daptomycin in Staphylococcus aureus, abstr. C1-683. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother.
61. Tally, F., M. Zeckel, M. Wasilewski, C. Carini, C. Berman, G. Drusano, and F. B. J. Oleson. 1999. Daptomycin: a novel agent for gram-positive infections. Expert Opin. Invest. Drugs. 8:1223-1238.
62. Tusher, V., R. Tibshirana, and C. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98:5116-5121.
63. Utaida, S., P. M. Dunman, D. Macapagal, E. Murphy, S. J. Projan, V. K. Singh, R. K. Jayaswal, and B. J. Wilkinson. 2003. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 149:2719-2732.
64. Waite, B. L., and R. W. Hutkins. 1998. Bacteriocins inhibit glucose PEP:PTS activity in Listeria monocytogenes by induced efflux of intracellular metabolites. J. Appl. Bacteriol. 85:287-292.
65. Wiedemann, I., E. Breukink, C. van Kraaij, O. P. Kuipers, G. Bierbaum, B. de Kruijff, and H. G. Sahl. 2001. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 276:1772-1779.
66. Wilkinson, B. J., A. Muthaiyan, and R. K. Jayaswal. 2005. The cell wall stress stimulon of Staphylococcus aureus and other gram-positive bacteria. Curr. Med. Chem. Anti-Infect. Agents. 4:259-276.
67. Wooton, M., A. P. MacGowan, and T. R. Walsh. 2006. Comparative bactericidal activities of daptomycin and vancomycin against glycopeptide-intermediate Staphylococcus aureus (GISA) and heterogeneous GISA isolates. Antimicrob. Agents Chemother. 50:4195-4197.
68. Yang, G., Y. Gao, J. Dong, C. Liu, Y. Xue, M. Fan, B. Shen, and N. Shao. 2005. A novel peptide screened by phage display can mimic TRAP antigen epitope against Staphylococcus aureus infections. J. Biol. Chem. 280:27431-27435.